Proportion of isolates with resistance to azithromycin reported to in Norway
Norway: Proportion of isolates with resistance to azithromycin reported to was 7.6 in 2020. ◆ Volatile
Proportion of isolates with resistance to azithromycin reported to in Norway, 2009–2020
Source: World Health Organization, Global Health Observatory.
Analysis
Norway recorded 7.6 for proportion of isolates with resistance to azithromycin reported to in 2020.
That represents a change of down 69.1% on the previous year and down 70.9% over ten years.
Over the whole period, proportion of isolates with resistance to azithromycin reported to in Norway peaked at 26.09 in 2010 and was at its lowest, 1.82, in 2009.
That places Norway 23rd out of 47 countries with data for 2020, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with resistance to azithromycin reported to in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 1.82 | — |
| 2010 | 26.09 | +1334.8% |
| 2011 | 3.9 | -85.1% |
| 2012 | 12.73 | +226.7% |
| 2013 | 10.71 | -15.8% |
| 2014 | 5.45 | -49.1% |
| 2015 | 3.64 | -33.3% |
| 2016 | 16.22 | +345.9% |
| 2017 | 14 | -13.7% |
| 2018 | 24.6 | +75.7% |
| 2020 | 7.6 | -69.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.82 | 1.82 | 1.82 | 1 |
| 2010s | 13.04 | 3.64 | 26.09 | 9 |
| 2020s | 7.6 | 7.6 | 7.6 | 1 |
Countries ranked near Norway
- 21 Spain 9.1 compare
- 22 Pakistan 8.51 compare
- 24 New Zealand 6.5 compare
- 25 Canada 6.1 compare
- 26 United States of America 5.8 compare
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Population ages 50-54, male, annual growth rate -0.9705 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0342 units per person (2025)
- Population ages 55-59, female, annual growth rate 1.36 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0324 units per person (2025)
Frequently asked questions
- What is proportion of isolates with resistance to azithromycin reported to in Norway?
- Proportion of isolates with resistance to azithromycin reported to in Norway was 7.6 in 2020, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to azithromycin reported to recorded in Norway?
- The highest recorded value was 26.09 in 2010.
- What is the lowest proportion of isolates with resistance to azithromycin reported to recorded in Norway?
- The lowest recorded value was 1.82 in 2009.
- How does Norway rank for proportion of isolates with resistance to azithromycin reported to?
- Norway ranks 23rd out of 47 countries with data for 2020.
- Is proportion of isolates with resistance to azithromycin reported to rising or falling in Norway?
- Over the last ten years it is down 70.9%. The long-run trend across the full record is volatile.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).